Yingjie Zhang
+
Gender:Male
Education Level:Postgraduate (Doctoral)
Alma Mater:山东大学
Paper Publications
- [121] xuwenfang and Yingjie Zhang. Progress of HDAC inhibitor panobinostat in the treatment of cancer. Curr. Drug Targets, 2014.
- [122] xuwenfang , liuxinyong and Yingjie Zhang. Discovery of N-substituted Oseltamivir Derivatives as Potent and Selective Inhibitors of H5N1 Influenza Neuraminidase. J. Med. Chem., 2014.
- [123] xuwenfang and Yingjie Zhang. Discovery of the First N-hydroxycinnamamide-based Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor Activity. J. Med. Chem., 2014.
- [124] Yingjie Zhang. Developments of Polo-like Kinase 1 (Plk1) Inhibitors as Anti-Cancer Agents. Mini. Rev. Med. Chem., 13, 2014, 2013.
- [125] Yingjie Zhang. Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity.. Chem. Biol. Drug Des., 82, 125, 2013.
- [126] Yingjie Zhang. Discovery of a pair of diastereomers as potent HDACs inhibitors: determination of absolute configuration, biological activity comparison and computational study.. Rsc Adv., 3, 21106, 2013.
- [127] Yingjie Zhang. Development of N-Hydroxycinnamamide-Based Histone Deacetylase Inhibitors with an Indole-Containing Cap Group.. ACS Med. Chem. Lett., 4, 235, 2013.
- [128] Yingjie Zhang. Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis andtumor growth.. Eur. J. Med. Chem., 64, 377, 2013.
- [129] Yingjie Zhang. Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part II.. Eur. J. Med. Chem., 69, 191, 2013.
- [130] Yingjie Zhang. Discovery of a fluorescent probe with HDAC6 selective inhibition. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 141, 596, 2017.